Clinical evaluation of NVL-520, a highly selective ROS1 inhibitor in patients with advanced ROS1-positive solid tumors: The phase I/II ARROS-1 study Meeting Abstract
| Authors: | Besse, B.; Johnson, M.; Ou, S. H. I.; Gadgeel, S.; Spira, A.; Lin, J.; Felip, E.; van der Wekken, A. J.; Calles, A.; de Miguel, M. J.; Camidge, D. R.; Elamin, Y.; Lopes, G. D. L.; Liu, S.; Bauman, J.; Haggstrom, D.; Riley, G.; Pelish, H. E.; Zhu, V. W.; Drilon, A. |
| Abstract Title: | Clinical evaluation of NVL-520, a highly selective ROS1 inhibitor in patients with advanced ROS1-positive solid tumors: The phase I/II ARROS-1 study |
| Meeting Title: | European Lung Cancer Congress (ELCC) 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Mar 30-Apr 2 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-04-01 |
| Start Page: | S68 |
| End Page: | S69 |
| Language: | English |
| ACCESSION: | WOS:000778453100079 |
| DOI: | 10.1016/j.annonc.2022.02.087 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 78TiP -- Source: Wos |
